CONMED Corporation
Every calculator, already run for CNMD
Open the full toolkit →You have the numbers on CNMD. Get the argument.
A written report on which of these readings actually decide the outcome for CONMED Corporation, what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
7 analysts covering CNMDAnalyst Price Target Disagreement for CONMED Corporation
Wall Street's bull case implies +4% from the current price; the bear case implies -9%. Analysts are relatively aligned on CNMD's range.
Ownership & short interest
Insider Trading Activity for CNMD
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as powered resection instruments, fluid management and visualization systems, and related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone p…
CNMD — frequently asked
Is CNMD a buy right now?
Wall Street's consensus rating on CONMED Corporation is Hold across 7 analysts, with a mean price target of $45.50 (-4% vs. the current $47.29). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is CNMD overvalued?
CNMD trades at 25.6x trailing earnings, against a DCF fair value of $128 per share. The current price implies -6% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is CNMD's next earnings date?
CONMED Corporation is next scheduled to report earnings around Oct 28, 2026. A full CNMD research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for CONMED Corporation?
Analysts covering CONMED Corporation (CNMD) range from a bear-case target of $43.00 to a bull-case high of $49.00, with a mean consensus target of $45.50 across 6 analysts. The spread of $6.00 (13% of the current price) indicates moderate disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare CONMED Corporation against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For CONMED Corporation
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full CNMD research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on CONMED Corporation, in minutes. 3 free reports included with every account — no credit card required.